Ixensor Co

Ixensor Co EBIT Margin

The EBIT Margin (Operating Margin) of Ixensor Co (6734.TWO) as of Nov 14, 2026 is -170.06 %. In the previous year, EBIT Margin (Operating Margin) was -236.83 % — a change of -28.19% (higher).

EBIT Margin

-170.06 %

YoY

-28.19%

Last updated:

EBIT Margin (Operating Margin) of Ixensor Co is 2025 -170.06 % . EBIT Margin (Operating Margin) of Ixensor Co was 2024 -236.83 % . It decreases by -28.19% higher compared to the previous year.

Ixensor Co's operating (EBIT) margin stands at -170.1%, up from -328.6% several years earlier.

The Ixensor Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
-951.58 TWD
Jan 1, 2019
-363.07 TWD
Jan 1, 2020
-502.56 TWD
Jan 1, 2021
-328.63 TWD
Jan 1, 2022
-4.97 TWD
Jan 1, 2023
-301.77 TWD
Jan 1, 2024
-236.83 TWD
Jan 1, 2025
-170.06 TWD
The Ixensor Co EBIT Margin history
YEAREBIT MarginYoY
-170.06 %-28.19%
-236.83 %-21.52%
-301.77 %+5,969.65%
-4.97 %-98.49%
-328.63 %-34.61%
-502.56 %+38.42%
-363.07 %-61.85%
-951.58 %+27.94%
-743.77 %-98.24%
-42,229.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ixensor Co Stock analysis

What does Ixensor Co do? iXensor Co., Ltd. generates revenue through its PixoTest Blood Glucose Monitoring System and ovulation detection system, targeting individuals managing diabetes and reproductive health. The company's technology platform measures biochemical parameters including blood sugar, luteinizing hormone, and cholesterol, providing data for diabetes management services. Its integrated medical device solutions serve customers seeking self-monitoring tools for chronic conditions and fertility tracking. The firm's products are designed for direct consumer use, with the PixoTest system offering blood glucose monitoring and the ovulation detection system supporting female hormone cycle management. These solutions leverage the company's platform to deliver personalized health insights without requiring third-party partnerships. The target segments include patients with diabetes and individuals tracking fertility cycles through biochemical monitoring. Ixensor Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ixensor Co stock

EBIT Margin (Operating Margin) of Ixensor Co is -170.06 % in 2025.

EBIT Margin (Operating Margin) of Ixensor Co changed from -236.83 % to -170.06 %, representing a -28.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Ixensor Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Ixensor Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Ixensor Co

All Key Metrics — Ixensor Co